The global market for pen needles is experiencing steady expansion, driven by critical healthcare trends such as rising diabetes prevalence, increased insulin dependency, and growing preference for home-based care. The market is witnessing increased investment from pharmaceutical companies, device manufacturers and healthcare systems aiming to improve continuing disease management in home and outpatient settings.
This report provides an overview of the global pen needles market and analyzes industry trends. The report examines key drivers, emerging trends, and significant players and provides market estimates through 2030.
The global market for pen needles is undergoing notable evolution, driven by rising diabetes prevalence, growing self-administration trends, and the push for enhanced injection safety and convenience. As injectable therapies expand beyond insulin, covering glucagon-like peptide-1 (GLP-1) receptor agonists, growth hormones (GHs) and biologics, the demand for precision-engineered, patient-friendly pen needles is accelerating. Innovations such as ultra-thin, tri-bevel needles, silicone lubrication and safetyengineered designs transform user experience, reduce injection pain and prevent needlestick injuries.
The report focuses on the significant driving trends and challenges that affect the market. It concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for pen needles. It also has a chapter of company profiles covering the details of key market players.
This report provides an overview of the global pen needles market and analyzes industry trends. The report examines key drivers, emerging trends, and significant players and provides market estimates through 2030.
The global market for pen needles is undergoing notable evolution, driven by rising diabetes prevalence, growing self-administration trends, and the push for enhanced injection safety and convenience. As injectable therapies expand beyond insulin, covering glucagon-like peptide-1 (GLP-1) receptor agonists, growth hormones (GHs) and biologics, the demand for precision-engineered, patient-friendly pen needles is accelerating. Innovations such as ultra-thin, tri-bevel needles, silicone lubrication and safetyengineered designs transform user experience, reduce injection pain and prevent needlestick injuries.
Report Scope
The report provides an overview of the global market for pen needles and analyzes market trends. It includes forecast global revenue ($ millions) for the base year 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented based on type, application, length and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa and South America, focusing on major countries in these regions.The report focuses on the significant driving trends and challenges that affect the market. It concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for pen needles. It also has a chapter of company profiles covering the details of key market players.
Report Includes
- An overview of the global market for pen needles
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, and estimated figures for 2025, including projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to pen needles, accompanied by a market share analysis based on type, application, needle length and region
- Analysis of current and future demand in the global pen needles market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Impact of U.S. tariffs on the pen needle industry
- Discussion on technological advancements, such as ultra-fine gauge needles and safety-engineered designs for patient comfort and compliance
- Review of patent grants for innovations related to pen needles across each major category
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Market share analysis of the key market participants in the market, along with their research priorities, product portfolios, global rankings and competitive landscape
- Profiles of major companies within the industry
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Emerging Technologies
Chapter 5 Market Segment Analysis
Chapter 6 Sustainability: An ESG Perspective in Pen Needles
Chapter 7 Competitive Intelligence
Chapter 8 Appendix
List of Tables
List of Figures
Companies Mentioned
- Advacare Pharma
- Allison Medical
- B. Braun Se
- Embecta Corp.
- Medical Technology And Devices S.P.A.
- Nipro
- Novo Nordisk A/S
- Owen Mumford Ltd.
- Terumo Corp.
- Ultimed Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 101 |
| Published | August 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 2.7 Billion |
| Forecasted Market Value ( USD | $ 4.2 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
